RxDoctor Payments Data

Kelly Gensel

Family · Wilkes Barre, PANPI 1073067286

Payments from drug & device makers

$8,247in general payments, 2019–2025

Across 445 payments — averaging $18.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vifor Pharma, Inc.$2K
  • Bayer$1K
  • AstraZeneca$720
  • Boehringer Ingelheim$598
  • Calliditas Therapeutics US Inc.$465
  • Daiichi Sankyo Inc.$436
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$7,93096%
  • Education$3184%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,247 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
VeltassaPatiromer Calcium Sorbitex31$35,716
KerendiaFinerenone15$12,445
LokelmaSodium Zirconium Cyclosilicate12$4,806
Potassium Chloride94$3,756
Calcium Acetate29$3,262
Doxazosin Mesylate135$2,670
Calcitriol231$2,345
Sevelamer Carbonate31$2,184
Clonidine Hcl75$1,294
Amlodipine Besylate141$1,231
Carvedilol86$1,073
Allopurinol78$922
Hydralazine Hcl62$852
Nifedipine ErNifedipine56$824
Furosemide159$746

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
BayerKerendia$1,013$12,44515 claims
AstraZenecaLokelma$720$4,80612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.

Other family in Wilkes Barre

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →